Beta Bionics, Inc. Common Stock

BBNXNASDAQ • USD
ThemeMedical Devices & HealthTech›Wearable Medical Devices
14.57 USD
↗ 1.22 (9.14%)AT CLOSE (11:59 AM EDT)
14.53
↘ 0.04 (0.31%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
14.53
↘ 0.04 (0.31%)
🔴Market: CLOSED

Beta Bionics, Inc. Common Stock (BBNX) trades at $14.52 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, BBNX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 4, 2026.

Open?$13.35
High?$14.58
Low?$13.33
Prev. Close?$13.35
Volume?3.3M
Avg. Volume?1.3M
VWAP?$14.04
Rel. Volume?2.62x
Bid / Ask
Bid?$12.50 × 100
Ask?$14.90 × 500
Spread?$2.40
Midpoint?$13.70
Valuation & Ratios
Market Cap?655.5M
Shares Out?45.0M
Float?28.3M
Float %?63.5%
P/E Ratio?N/A
P/B Ratio?2.56
EPS?-$1.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Themes
Medical Devices & HealthTech›Wearable Medical DevicesDigital Health & Telemedicine›Remote Patient Monitoring
Employees
423
Market Cap
600.6M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.betabionics.com
Listed
2025-01-30
Address
11 HUGHES
IRVINE, CA 92618
Phone: 949-427-7785
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
85
Short Sent.?
25
Piotroski F-Score?0/9Weak
Altman Z-Score?9.24Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?23.35%Squeeze Risk
Short Interest?6.6M
Days to Cover?7.0
Free Float28.3M
Avg Daily Volume948.7K
Settlement Date2026-07-15
Financial Health
Current Ratio?8.88Strong
Quick Ratio?7.96Strong
Cash Ratio?1.70Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
63
2.56CHEAP▾
P/S?
Peers
100
S&P
25
5.51FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.6CHEAP▾
EV/Sales?
Peers
100
S&P
35
5.14FAIR▾
Returns & Efficiency
ROE?
S&P
6
-28.5%WEAK▾
ROA?
S&P
3
-25.0%WEAK▾
Cash Flow & Enterprise
FCF?$-61411000
Enterprise Value?$611.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist